Related Experiment Video
Updated: Apr 7, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
Published on: September 20, 2016
Understanding next generation sequencing in oncology: A guide for oncologists
Sing Yu Moorcraft1, David Gonzalez1, Brian A Walker1
1The Royal Marsden NHS Foundation Trust, Surrey, United Kingdom.
Next-generation sequencing (NGS) offers faster, cheaper DNA analysis for clinical use. This review clarifies NGS technology, data interpretation, and platform selection for oncologists, addressing challenges in its routine clinical application.
Area of Science:
- Genomics
- Oncology
- Biotechnology
Background:
- Next-generation sequencing (NGS) has revolutionized DNA analysis, making it faster and more affordable.
- NGS is increasingly adopted in clinical settings, moving beyond research applications.
- Oncologists face challenges understanding NGS terminology, data interpretation, and platform differences due to workload and training gaps.
Purpose of the Study:
- To demystify common concepts and terminology associated with DNA sequencing.
- To provide a comprehensive overview of the DNA sequencing process, including data analysis.
- To guide oncologists in selecting appropriate sequencing methods and understanding platform variations.
Main Methods:
- Review of current literature on next-generation sequencing technologies.
- Explanation of fundamental DNA sequencing principles and data analysis workflows.
- Discussion of practical considerations for choosing sequencing platforms in clinical oncology.
Main Results:
- Clarification of key NGS concepts and terminology relevant to oncologists.
- Summary of the end-to-end DNA sequencing process from sample to data.
- Identification of critical factors for selecting sequencing methods and platforms.
Conclusions:
- Enhanced understanding of NGS platforms and data interpretation is crucial for oncologists.
- Addressing training needs and simplifying complex information will facilitate NGS integration.
- Overcoming current challenges is essential for the broader adoption of NGS in routine clinical oncology practice.
More Related Videos
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
Related Concept Videos
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
Sanger Sequencing
RNA-seq
Before the discovery of RNA-seq, microarray-based methods and Sanger sequencing were used for transcriptome analysis. However, while...
Maxam-Gilbert Sequencing
Challenges of the Maxam-Gilbert Method
The...
Genomics
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...